Stephens Investment Management Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-908
Closed -$101K – 182
2022
Q1
$101K Hold
908
– – ﹤0.01% 180
2021
Q4
$94K Hold
908
– – ﹤0.01% 183
2021
Q3
$114K Hold
908
– – ﹤0.01% 182
2021
Q2
$113K Hold
908
– – ﹤0.01% 181
2021
Q1
$107K Hold
908
– – ﹤0.01% 178
2020
Q4
$106K Buy
908
+104
+13% +$11.4K ﹤0.01% 175
2020
Q3
$84K Buy
804
+205
+34% +$20.6K ﹤0.01% 170
2020
Q2
$55K Buy
+599
New +$57.4K ﹤0.01% 166

Other funds holding MDT

Stephens Investment Management Group's MDT Position: Q2 2022 in Review

Stephens Investment Management Group sold out of Medtronic (MDT) in Q2 2022, closing a stake of 908 shares — an estimated $101K sold.

Stephens Investment Management Group first reported a position in MDT in Q2 2020 and held it in 8 quarters. The position peaked at $114K in Q3 2021. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Stephens Investment Management Group reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Stephens Investment Management Group sold 908 Medtronic shares in Q2 2022, an estimated $101K.
  • Stephens Investment Management Group first reported a position in Medtronic in Q2 2020 and held it in 8 quarters.
  • Stephens Investment Management Group's Medtronic position peaked at $114K in Q3 2021.
  • 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Stephens Investment Management Group's 13F filing for Q2 2022, filed 3 Aug 2022.